Emmaus Life Sciences, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Emmaus Life Sciences, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2010 to Q3 2024.
  • Emmaus Life Sciences, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was $1.83M, a 2627% increase year-over-year.
  • Emmaus Life Sciences, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$3.5M, a 26.3% increase year-over-year.
  • Emmaus Life Sciences, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$3.73M, a 64.9% increase from 2022.
  • Emmaus Life Sciences, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$10.6M, a 33.4% increase from 2021.
  • Emmaus Life Sciences, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$15.9M, a 1278% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$3.5M $1.83M +$1.76M +2627% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-19
Q2 2024 -$5.26M -$2.18M -$626K -40.2% Apr 1, 2024 Jun 30, 2024 10-Q 2024-11-19
Q1 2024 -$4.63M -$4.35M -$897K -26% Jan 1, 2024 Mar 31, 2024 10-Q 2024-11-19
Q4 2023 -$3.73M $1.21M +$1.01M +505% Oct 1, 2023 Dec 31, 2023 10-K 2024-07-03
Q3 2023 -$4.74M $67K +$458K Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-19
Q2 2023 -$5.2M -$1.56M +$7.33M +82.5% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-19
Q1 2023 -$12.5M -$3.45M -$1.91M -124% Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-19
Q4 2022 -$10.6M $200K +$7.06M Oct 1, 2022 Dec 31, 2022 10-K 2024-07-03
Q3 2022 -$17.7M -$391K +$2.76M +87.6% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$20.4M -$8.89M -$11.4M -457% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-14
Q1 2022 -$9.07M -$1.54M +$6.88M +81.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-14
Q4 2021 -$15.9M -$6.86M -$6.6M -2470% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 -$9.35M -$3.15M -$8.74M -156% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$615K $2.49M +$12M Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-14
Q1 2021 -$12.6M -$8.42M -$13.9M -253% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-14
Q4 2020 $1.35M -$267K +$1.18M +81.5% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 $175K $5.59M +$24M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 -$23.8M -$9.47M +$8.12M +46.2% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-12
Q1 2020 -$31.9M $5.51M +$22.9M Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-12
Q4 2019 -$54.8M -$1.45M +$932K +39.2% Oct 1, 2019 Dec 31, 2019 10-K/A 2021-08-10
Q3 2019 -$55.8M -$18.4M -$33M -226% Jul 1, 2019 Sep 30, 2019 10-Q 2021-08-26
Q2 2019 -$22.8M -$17.6M +$29.7M +62.8% Apr 1, 2019 Jun 30, 2019 10-Q 2021-08-26
Q1 2019 -$52.6M -$17.4M -$14.8M -573% Jan 1, 2019 Mar 31, 2019 10-Q 2021-08-26
Q4 2018 -$37.7M -$2.38M +$392K +14.1% Oct 1, 2018 Dec 31, 2018 10-Q 2019-02-14
Q3 2018 -$38.1M $14.6M +$17.2M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-13
Q2 2018 -$55.3M -$47.3M -$45.8M -2911% Apr 1, 2018 Jun 30, 2018 8-K/A 2019-08-14
Q1 2018 -$9.58M -$2.59M -$1.14M -78.2% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-13
Q4 2017 -$8.44M -$2.77M -$1.33M -92.3% Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-14
Q3 2017 -$7.11M -$2.65M -$1.66M -167% Jul 1, 2017 Sep 30, 2017 10-K 2018-12-11
Q2 2017 -$5.46M -$1.57M -$218K -16.1% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-10
Q1 2017 -$5.24M -$1.45M -$1.31M -918% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-14
Q4 2016 -$3.93M -$1.44M +$2.01M +58.3% Oct 1, 2016 Dec 31, 2016 10-Q 2018-02-20
Q3 2016 -$5.94M -$993K +$279K +22% Jul 1, 2016 Sep 30, 2016 10-K 2017-12-29
Q2 2016 -$6.22M -$1.35M -$818K -152% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 -$5.4M -$143K +$554K +79.5% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 -$5.96M -$3.45M -$2.58M -295% Oct 1, 2015 Dec 31, 2015 10-Q/A 2017-03-30
Q3 2015 -$3.38M -$1.27M -$435K -51.9% Jul 1, 2015 Sep 30, 2015 10-K 2016-12-22
Q2 2015 -$2.94M -$537K +$482K +47.3% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-15
Q1 2015 -$3.43M -$696K +$246K +26.1% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-16
Q4 2014 -$3.67M -$875K -$1.01M -747% Oct 1, 2014 Dec 31, 2014 10-Q 2016-02-17
Q3 2014 -$2.66M -$837K +$6.23M +88.2% Jul 1, 2014 Sep 30, 2014 10-K 2016-01-05
Q2 2014 -$8.89M -$1.02M +$315K +23.6% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-14
Q1 2014 -$9.21M -$942K +$589K +38.5% Jan 1, 2014 Mar 31, 2014 10-Q/A 2015-05-18
Q4 2013 -$9.8M $135K +$1.11M Oct 1, 2013 Dec 31, 2013 10-Q 2015-02-13
Q3 2013 -$10.9M -$7.07M -$11.2M -272% Jul 1, 2013 Sep 30, 2013 10-K 2014-12-29
Q2 2013 $265K -$1.33M -$4.95M -137% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-14
Q1 2013 $5.21M -$1.53M +$6.86M +81.8% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-15
Q4 2012 -$1.65M -$973K +$1.76M +64.4% Oct 1, 2012 Dec 31, 2012 10-Q 2014-02-13
Q3 2012 -$3.41M $4.1M +$6.8M Jul 1, 2012 Sep 30, 2012 10-K 2013-12-23
Q2 2012 -$10.2M $3.62M +$2.74M +314% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-14
Q1 2012 -$12.9M -$8.39M -$1.45M -20.8% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
Q4 2011 -$11.5M -$2.73M -$2.63M -2696% Oct 1, 2011 Dec 31, 2011 10-Q/A 2013-02-22
Q3 2011 -$8.87M -$2.7M Jul 1, 2011 Sep 30, 2011 10-K 2013-01-15
Q2 2011 $873K +$2.37M Apr 1, 2011 Jun 30, 2011 10-Q/A 2012-09-11
Q1 2011 -$6.95M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-15
Q4 2010 -$97.7K Oct 1, 2010 Dec 31, 2010 10-Q 2012-02-14
Q2 2010 -$1.5M Apr 1, 2010 Jun 30, 2010 10-Q/A 2011-09-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.